AMERICAN SHARED HOSPITAL SERVICES Lease, Cost
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Lease, Cost of $101.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-08-13
- AMERICAN SHARED HOSPITAL SERVICES lease, cost for the quarter ending 2026-06-30 was $101.00K, a 55.38% increase year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES lease, cost for the quarter ending 2026-03-31 was $118.00K, a 16.90% decline year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES lease, cost for the quarter ending 2025-12-31 was $325.00K, a 40.09% increase year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES lease, cost for the quarter ending 2025-09-30 was $61.00K, a 48.31% decline year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES lease, cost for fiscal 2025 was $593.00K, a 38.88% increase from fiscal 2024.
- AMERICAN SHARED HOSPITAL SERVICES lease, cost for fiscal 2024 was $427.00K, a 146.82% increase from fiscal 2023.
- AMERICAN SHARED HOSPITAL SERVICES lease, cost for fiscal 2023 was $173.00K, a 25.43% decline from fiscal 2022.
- AMERICAN SHARED HOSPITAL SERVICES lease, cost for fiscal 2022 was $232.00K, a 31.16% decline from fiscal 2021.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month | Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $101.00K 10-Q · filed 2026-08-13 | $219.00K 10-Q · filed 2026-08-13 | $544.00K derived: sum of 3 quarters · filed 2026-08-13 | $605.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | $118.00K 10-Q · filed 2026-05-14 | $443.00K derived: sum of 2 quarters · filed 2026-05-14 | $504.00K derived: sum of 3 quarters · filed 2026-05-14 | $569.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | $325.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-31 | $386.00K derived: sum of 2 quarters · filed 2026-03-31 | $451.00K derived: sum of 3 quarters · filed 2026-08-13 | $593.00K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $61.00K 10-Q/A · filed 2026-01-16 | $126.00K derived: sum of 2 quarters · filed 2026-08-13 | $268.00K 10-Q/A · filed 2026-01-16 | $500.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | $65.00K 10-Q · filed 2026-08-13 | $207.00K 10-Q · filed 2026-08-13 | $439.00K derived: sum of 3 quarters · filed 2026-08-13 | $557.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | $142.00K 10-Q · filed 2026-05-14 | $374.00K derived: sum of 2 quarters · filed 2026-05-14 | $492.00K derived: sum of 3 quarters · filed 2026-05-14 | $497.00K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $232.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-31 | $350.00K derived: sum of 2 quarters · filed 2026-03-31 | $355.00K derived: sum of 3 quarters · filed 2026-03-31 | $427.00K 10-K · filed 2026-03-31 | $263.00K 10-K · filed 2025-04-04 |
| 2024-09-30 | $118.00K 10-Q/A · filed 2026-01-16 | $123.00K derived: sum of 2 quarters · filed 2026-01-16 | $195.00K 10-Q/A · filed 2026-01-16 | $181.00K derived: sum of 4 quarters · filed 2026-01-16 | |
| 2024-06-30 | $5.00K 10-Q · filed 2025-08-13 | $26.00K 10-Q · filed 2025-08-13 | $63.00K derived: sum of 3 quarters · filed 2025-08-13 | $92.00K derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | $21.00K 10-Q · filed 2025-05-15 | $58.00K derived: sum of 2 quarters · filed 2025-05-15 | $87.00K derived: sum of 3 quarters · filed 2025-05-15 | $141.00K derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | $66.00K derived: sum of 2 quarters · filed 2025-04-04 | $120.00K derived: sum of 3 quarters · filed 2025-04-04 | $173.00K 10-K · filed 2025-04-04 | |
| 2023-09-30 | $29.00K 10-Q · filed 2024-11-14 | $83.00K derived: sum of 2 quarters · filed 2024-11-14 | $136.00K 10-Q · filed 2024-11-14 | $194.00K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $54.00K 10-Q · filed 2024-08-14 | $107.00K 10-Q · filed 2024-08-14 | $165.00K derived: sum of 3 quarters · filed 2024-08-14 | $224.00K derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $53.00K 10-Q · filed 2024-05-15 | $111.00K derived: sum of 2 quarters · filed 2024-05-15 | $170.00K derived: sum of 3 quarters · filed 2024-05-15 | $228.00K derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $117.00K derived: sum of 2 quarters · filed 2024-04-01 | $175.00K derived: sum of 3 quarters · filed 2024-04-01 | $232.00K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $59.00K 10-Q · filed 2023-11-14 | $117.00K derived: sum of 2 quarters · filed 2023-11-14 | $174.00K 10-Q · filed 2023-11-14 | $253.00K derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $58.00K 10-Q · filed 2023-08-14 | $116.00K 10-Q · filed 2023-08-14 | $194.00K derived: sum of 3 quarters · filed 2023-08-14 | $281.00K derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | $57.00K 10-Q · filed 2023-05-12 | $136.00K derived: sum of 2 quarters · filed 2023-05-12 | $223.00K derived: sum of 3 quarters · filed 2023-05-12 | $309.00K derived: sum of 4 quarters · filed 2023-05-12 | |
| 2021-12-31 | $79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $166.00K derived: sum of 2 quarters · filed 2023-03-31 | $252.00K derived: sum of 3 quarters · filed 2023-03-31 | $337.00K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $87.00K 10-Q · filed 2022-11-10 | $173.00K derived: sum of 2 quarters · filed 2022-11-10 | $258.00K 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $86.00K 10-Q · filed 2022-08-15 | $171.00K 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |